By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Accept

Shareholder Resources

Press Releases and Letters

April 17, 2023
Leading Proxy Advisory Firms ISS and Glass Lewis Demonstrate Strong Support for Zevra’s Transformation Strategy
Download PDF
March 29, 2023
Zevra Therapeutics Mails Letter to Shareholders
Download Letter
March 15, 2023
Zevra Therapeutics Files Definitive Proxy Statement and Mails Letter to Shareholders
Download PDFDownload Letter
March 7, 2023
Zevra Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Corporate Updates
Download PDFDownload Transcript
February 27, 2023
Zevra Therapeutics, a Rare Disease Therapeutics Company, Files Preliminary Proxy
Download PDF

Investor Presentations and Events

April 5, 2023
Zevra Therapeutics: Clear Strategic Direction Under Refreshed Board
Download PDF
March 13, 2023
Zevra Therapeutics at 2023 Roth Conference
View VideoDownload Transcript
March 7, 2023
Zevra Quarterly Results Presentation – Q4 and FY 2022 Results
Download PDF

Proxy Resources

Zevra Infographic
Download PDF
Definitive Proxy Statement
Download PDF

We urge you to protect the value of your investment in Zevra by voting on the WHITE proxy card “FOR” the re-election of your highly experienced and qualified Board nominees, Richard W. Pascoe, David S. Tierney, M.D., and Christopher A. Posner.

DO NOT vote for any of the Mangless nominees. Vote “AGAINST” the Mangless Proposal.
How to Vote

Vote on your WHITE proxy card to support value creation at Zevra. If you have questions or need assistance voting your shares, please contact our proxy solicitor:

Morrow Sodali LLC
509 Madison Avenue, 12th Floor
New York, NY 10022
Toll-free: 1 (800) 662-5200 or (203) 658-9400
Email: ZVRA@info.morrowsodali.com

Investors

Nichol Ochsner
‍+1 (732) 754-2545
‍nochsner@zevra.com

Media

Jennifer Arcure
+1 (917) 603-0681
‍Jennifer.arcure@evokegroup.com

Michael Freitag / Tim Lynch / Tim Ragones
Joele Frank, Wilkinson Brimmer Katcher
+1 (212) 355-4449